Cite this asde Andrade DP, Silva Carvalho IC, Godoi BH, da Silva NS, Soares CP, et al. (2020) In vitro genotoxic study reinforces the use of titanium-35niobium alloy in biomedical implants. Int J Oral Craniofac Sci 6(1): 008-015. DOI: 10.17352/2455-4634.000044
Titanium-Niobium (TiNb) alloys have been considered a good alternative for several biomedical applications. Titanium-35niobium (Ti-35Nb) alloy has an excellent biological profile and shows a great potential for biomedical application in both the orthopedic and dentistry fields. In this study, the comet assay and micronucleus assays, sensitive assays for DNA damage, were used to evaluate potential genotoxicity in model cell type exposed to Ti-35Nb alloy and pure titanium (Ti pure). Human osteosarcoma cells (MG63) were exposed to Ti-35Nb and Ti pure extracts and DNA damage assessed at 24 h, 48 h, and 72 h. The assays, comet and micronucleus, showed that Ti-35Nb alloy did not cause damage to the cells DNA. Our results demonstrated that Ti-35Nb alloy does not present genotoxicity, reinforcing that this alloy is a promising material and constitutes an alternative in the substitution to the materials currently used in orthopedics and in dentistry.
The applications of titanium based alloys are widely used as orthopedic implants due to their excellent combination of mechanical properties, corrosion resistance and outstanding biocompatibility. Recently studies have been demonstrated titanium-niobium alloys do not present cytotoxicity, exhibit corrosion resistance similar or superior to titanium and have elastic modulus significantly lower than other titanium alloys. These characteristics make these materials an alternative for several biomedical applications, mainly implants. Previous studies demonstrated that Ti-35Nb alloy exhibits the closest elastic modulus of bone, and have good performance in key parameters of osteogenesis, which means that this alloy has an excellent biological profile and shows a great potential for biomedical application. In the present study it was demonstrated that Ti-35Nb alloy did not present DNA damage. Thus, these results consolidate this alloy has a promising material to substitution to the materials currently used in orthopedics and in dentistry, with absence of cytotoxity and genotoxity.
About 70 to 80% of biomedical implants are made of metallic materials, and this demand has grown over the years, due to the increase in life expectancy of the population. Even with these numbers, biological and mechanical properties of metallic biomaterials are not ideal, requiring improvements .
Titanium-Niobium (TiNb) alloys have characteristics that make these materials an alternative for several biomedical applications, mainly implants [2-4]. According to experimental studies, these alloys do not present cytotoxicity, exhibit corrosion resistance similar or superior to Titanium (Ti) and have elastic modulus significantly lower than other titanium alloys [3-11].
The titanium-35niobium (Ti-35Nb) is a binary alloy that was developed by our research group and its main characteristic is to exhibit the closest elastic modulus of bone (80.7 GPa) . In previous study it was demonstrated that Ti-35Nb alloy has good performance in key parameters of osteogenesis in rat calvaria-derived cell cultures . In another study it was showed the molecular mechanisms of interaction between human osteoblasts and the Ti-35Nb alloy follow the principal osseointegration routes of commercially pure titanium, and the expression of key markers of cell adhesion and differentiation indicate that the induction of bone matrix synthesis was similar for Ti-35Nb alloy and commercially pure titanium . Additionally, recent In vitro and in vivo studies present evaluations of powder metallurgy-processed porous samples composed by different titanium alloys and pure Ti, aiming to show their potential for biomedical applications. The results showed that Ti-35Nb alloy have better results than commercially pure titanium and Ti-6 Aluminium-4 Vanadium alloy, the most common materials implants composition, in gene expression and cytokines analysis [13-15]. These results demonstrate that Ti-35Nb alloy has an excellent biological profile and shows a great potential for biomedical application in both the orthopedic and dentistry fields.
However, the biological properties of new biomaterials must be studied to fully explore potential side effects, and a very important parameter had been neglected by studies evaluating the biological properties of new materials, which is the genotoxic potential of biomaterials. The literature describes several studies that aimed to determine the biomaterials cytotoxicity, but few recent studies have emphasized the importance of evaluating the biomaterials genotoxicity [4,6,7,16-24].
Genotoxic agents can be defined functionally as having the ability to alter DNA replication and genetic transmission. The major endpoints of short-term genotoxicity assays include DNA damage, point mutations, and chromosomal aberrations . Thus, genotoxicity describes the capacity of an agent that damages the genetic information in a cell, causing mutations.
The biomaterials interact with the body, consequently, it is very important to evaluate the mutagenic potential of medical biomaterials in the final form. To establish the Ti-35Nb alloy as a biomedical material it is important to evaluate the possibility of this material being genotoxic or not to the organism. Thus, the aim of this study was to examine the genotoxicity of Ti-35Nb alloy In vitro using the comet and micronucleus assays. Human osteosarcoma cells (MG63) were used, a type of model cell types commonly used in biomaterials research. The comet and micronucleus assays were performed in Ti-35Nb alloy extracts.
Dense and porous Ti and Ti–35Nb samples were prepared using Ti powders with purity C99.5% and particle size 8 μm, which were formed by hydrogenation and dehydrogenation, the samples were prepared by powder metallurgy, developed at the Materials Division of the Aeronautics and Space Institute of the General Command of Aerospace Technology, São José dos Campos, São Paulo, Brazil. Interconnected pores were obtained in samples of Ti and Ti–35Nb alloy using a mixed powder with an organic additive (urea), with particles ranging from 177 to 250 μm used as space holders.
Dense and porous samples with the test alloy (Ti-35Nb) and pure titanium (pure titanium grade 2) were manufactured in the form of 12 mm diameter disks by 2 mm high. The procedures of samples manufacture were described and presented in a previous study by our research group in Andrade, et al. . and the Ti-35NB alloy was developed previously by Santos, et al. . Four types of samples were prepared: a) Dense Ti pure; b) Porous Ti pure; c) Dense Ti-35Nb alloy; and d) Porous Ti-35Nb alloy. All the samples were sterilized by Gamma radiation at 20 kGy (Embrarad, Empresa Brasileira de Radiações Ltda, Cotia, SP, Brazil) before the cell assay.
The Ti pure groups (Dense Ti pure and Porous Ti pure) were used to compare with a control group, since this material has been widely used in implants. The dense and porous samples were used in order to verify if the material porosity would influence the materials genotoxicity.
In the present study the genotoxicity of the Ti-35Nb alloy was evaluated by the indirect contact of the samples extracts with the cells, as recommended by ISO 10993-5:2009 directions . This methodology was chosen because direct contact with the sample did not allow sufficient numbers of cells for the comet and micronucleus assays. Porous samples allow the cells interiorization favoring an osseointegration, but they make it difficult to remove the cells for the cell assays due to differences in the surface depth of the samples, which have pores of several sizes and shapes, as demonstrated by Andrade, et al. . by Scanning Electron Microscopy (SEM).
The samples extracts were obtained following the EN ISO 10993-5:2009 directions . Briefly, 2 samples disks by group (7 g of samples-this quantity of sample was chosen according to EN ISO 10993-5:2009 regulations for the extracts preparation) were put in 20 ml of culture medium Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Grand Island, NY, USA) . The flasks were then incubated at 37 °C in a humidified 5% CO2 for 7 days under stirring at 75 rpm (Cientec CT-712R). Then, the samples were removed from the flasks and the different sample extracts were supplemented with 10% fetal bovine serum (FBS) (Gibco) and 1% antibiotic-antimycotic (Gibco).
Human osteosarcoma cells (MG63 line, Banco de Células do Rio de Janeiro, Duque de Caxias, RJ, Brazil) were grown as a monolayer culture in 25-cm2 flasks containing DMEM (Gibco) supplemented with 10% FBS (Gibco) and 1% of antibiotic-antimycotic (Gibco) until confluent. The cells were cultured at 37 °C, 95% humidity and 5% CO2. The culture medium was changed every 2–3 days. Culture progression was evaluated by phase contrast microscopy (Inverted Microscope OLYMPUS CK40). When the cells reached approximately 80% of confluence, they were detached by a mixture of trypsin/EDTA (0.25%) (Gibco) at 37 °C for 3 minutes and seeded in 24-well polystyrene plates at 2x104 cells/well in 500µL of culture medium according to the experimental group. The control group of the cells were seeded in 24-well polystyrene plates at 2x104 cells/well in 500µL of DMEM (Gibco) supplemented with 10% FBS (Gibco) and 1% of antibiotic-antimycotic (Gibco). The cells were seeded in 24-well polystyrene plates at 2x104 cells/well in 500µL of respectively sample extracts for Dense Ti pure, Porous Ti pure, Dense Ti-35Nb alloy, and Porous Ti-35Nb alloy, supplemented with 10% FBS (Gibco) and 1% antibiotic-antimycotic (Gibco).
Three wells were seeded from each group and all the assays were performed in triplicate (n = 9 well/ group).
The comet assay protocol was performed by Carvalho, et al. . Cells were cultured for 24h, 48h and 72h in 24-well polystyrene plates with cell density of 2x104 with their respective sample extract. After each period, 200μl of trypsin/0.25% EDTA (Gibco) was added to each well of the plate for 3 min to detach the cells. After centrifugation (3000 rpm/5 min), each group of cells was resuspended in 200μl of 0.5% low-melting point agarose (37 ºC) (Gibco) and transferred to slides recently prepared with 1.5% agarose (60 ºC) (Gibco). The slides were immersed in freshly prepared cold (4 ºC) lysis solution (NaCl 2.5 M, EDTA 100mM, Tris 10 mM/ 1% Triton X-100, 10% DMSO, ph=7.65) and kept at 4 °C for 1h. The prepared slides were placed in a horizontal electrophoresis cube, which was then filled up with freshly made alkaline buffer at 4 °C (300 mM NaOH and 1 mM EDTA, pH 13). Electrophoresis was performed at 300 mA and 25 V for 30 min. The slides were removed, placed in horizontal position and washed three times (5 min each) with 0.4 M TRIS –HCl, pH 7.5. A 30 μl volume of ethidium bromide (20 µg/mL) was added to stain the slides, and the readings were immediately taken under a Epifluorescence microscope (Leica Epifluorescence Microscope DMIB with camera to capture pictures model Leica DFC310FX) at 200 x magnification. For this test, three slides were prepared per well by each group. Ten (10) randomly selected fields per slides were photographed and analysis was performed in 250 randomly selected cells per group. The images were analyzed in the OpenComet analysis software program, and statistically analyzed by the Graphpad Prism 6.0 software program (GraphPad Inc., La Jolla, CA, USA).
The micronucleus assay protocol was performed by Carvalho, et al. . Cells were cultured for 24h, 48h and 72h in 24-well polystyrene plates with cell density of 2x104 with their respective sample extract. After each period, the cells were washed twice with Phosphate-Buffered Saline (PBS) and fixed in 4% paraformaldehyde in phosphate buffer for 10 min at room temperature. Then the cells were washed again with PBS and incubated with 200 µL DAPI (4’,6-Diamino-2-Phenylindole, Sigma/Aldrich, St. Louis, USA) in 300 nM phosphate buffer for 10 min at room temperature. The number of cells with micronuclei was counted with the aid of a fluorescence microscope (Leica Fluorescence Microscope DMIL with camera to capture pictures model Leica DFC310FX) and software Leica Application Suite V3 (400x magnification) in 10 different fields of each well, a total of 30 fields per experimental group. The micronuclei frequency was calculated as the number of cells with micronucleus per 1000 cells per experimental group. The analyses were carried out by one of the co-authors (B.H.G.), who was blind to identification. The criteria used to identify micronuclei were those defined by Tikenko-Holand . Statistical analysis was performed with the Graphpad Prism 6.0 software program (GraphPad Inc., La Jolla, CA, USA).
The data are not normally distributed (Kolmogorov-Smirnov test) and statistical analysis was performed by using Kruskal-Wallis with Dunn’s multiple comparisons posttest in GraphPad Prism 6.0 software (GraphPad Inc., La Jolla, CA). No statistical adjustment was applied to the samples. The comet assay data were expressed as median with interquartile range values for 250 cells analyzed per experimental group. The micronucleus assay data were expressed as mean and standard deviation (SD) for 1000 cells analyzed per experimental group. Statistical significance was set at 0.05.
The percentage of DNA in the comet tail was not significantly different among the groups in 24 h (p= 0.6642), 48 h (p= 0.6281) and 72 h (p=0.4986) (Figure 1A). Additionally, when compared among the periods of 24 h, 48 h and 72 h the percentage of DNA in the comet tail was statistically equal for all groups (Control group p= 0.6297; Dense Ti pure p= 0.2713; Porous Ti pure p= 0.6249; Dense Ti-35Nb alloy p= 0.3390; and Porous Ti-35Nb alloy p= 0.4823) (Figure 1B). Figure 2 shows some examples of cells submitted to electrophoresis for DNA fragmentation assessment before (A) and after analysis (B) in the OpenComet software.
The micronucleus frequency did not show significant difference among groups at 24 h (p=0.3976), 48 h (p>0.9999) and 72 h (p=0.2762) (Figure 2A). Intra-group comparison of the 24 h, 48 h and 72 h periods (Figure 2B) showed that the number of micronucleus in most groups was not significantly different (Control p=0.2500; Dense Ti pure p=0.1429; Porous Ti pure p=0.1643; Porous Ti-35Nb alloy p=0.3571), however the Dense Ti-35Nb alloy presented significant difference (p=0.0357). Figure 3 shows cells nucleus labeled with DAPI. All groups (Control, Dense Ti pure, Porous Ti pure, Dense Ti-35Nb alloy, and Porous Ti-35Nb alloy) presented a large number of cells in the evaluated periods (24 h, 48 h and 72h).
Ti alloys have been studied extensively as an alternative for several biomedical applications, mainly implants [16,17]. However, the biomaterials implantation and their duration in the human body have increased steadily, thus, it is necessary to study their long-term effects. One of the most striking issues is the biomaterial potential to cause cancer, a concern dealt with in the medical devices regulation (ISO 10993-3) .
Previous studies showed that Ti-35Nb alloy was not cytotoxic and presented an excellent biological profile, similar to that of titanium, and is a promising material in the substitution of the materials currently used for the orthopedic and dentistry implants [4,12,13].
Nevertheless, in order to fully understand risks associated with their clinical application, potential side effects should be evaluated. In this study, DNA strand breaks and levels of unrepaired cellular DNA damage were measured using two simple and reproducible techniques, the comet and micronucleus assay, and the results showed that Ti-35Nb alloy did not present genotoxicity, confirming the great potential of use of this alloy.
The comet assay, also known as single-cell gel electrophoresis (SCGE), is a standard test in the battery of tests used to assess of novel pharmaceuticals or other chemicals . Additionally, according to ISO 10993, an international standard, all materials that will be in contact with mucous, bone, or dentinal tissue if the contact exceeds 30 days, as well as all implantable devices if the contact exceeds 24 h, must undergo genotoxicity testing. Therefore, this technique has been extensively used in assessing genotoxic effects in cells exposed to various toxicants, including the evaluation of the toxicity potential to biomaterials [19,20,24,26,27,31-34].
The comet assay is an efficient, sensitive and rapid method for measuring DNA damages in individual’s cells of any type [25,35-38]. This method detects strand breaks, alkali-labile sites, DNA cross-linking, and incomplete excision repair sites and these DNA damages can be analyzed manually by the authors, classifying the size of the comet tail in five classes resulting in a single DNA damage score for each individual cell, or by an automated comet assay image analysis tool [25,35,39-42]. Many automated comet assay image analysis tools have been developed and used in studies [27,37,43]. These automated tools are more accurate, less prone to human bias and faster than manual analysis, thus, the OpenComet software was used [37,43].
The results of this study revealed that Ti-35Nb alloy, as well as Ti pure, a biomaterial already used in implants, did not cause damage to the cells DNA compared with the Control group. Moreover, it was found that there was no statistical difference among the groups Ti-35Nb dense and porous when compared with the Control group. In the same way, there was no statistical difference among the groups Dense Ti pure and Porous Ti when compared with the Control group, showing that the surface topography of the material also did not influence in the genotoxicity. It means that, although the pores formation on the implant surface significantly increases the area of bone-implant contact due to bone growth in the interior of the pores (bone ingrowth), resulting in the acceleration of osseointegration, the surface topography did not influence in the genotoxicity [44,45].
Micronuclei originate from acentric chromosome fragments that are caused by DNA strand breaks and also by chromosome malsegregation events during the cell cycle interphase. Thus, the micronucleus assay is a method for measuring spontaneous and induced chromosomal damage and separation errors, therefore, this technique can be used to detect chromosomal mutations, clastogenicity, and aneugenicity [46,47].
Several studies have used this method to detect genotoxicity, including in biomaterials [27,41,48-55,56,57]. Our results of the micronucleus assay corroborate with the results of the comet assay, which means, they demonstrated that the Ti-35Nb alloy, as well as Ti pure, were not genotoxic, and the material surface topography also did not influence in the genotoxicity. However, in intra-group comparison of the 24 h, 48 h and 72 h periods showed that the number of micronucleus in the Dense Ti-35Nb alloy presented significant statistical difference (p=0.0357). This difference occurred because in 24 h the Ti-35Nb alloy presented micronuclei, but in the other periods (48 h and 72 h) the presence of micronuclei was not observed. However, this statistical difference does not mean that this alloy is genotoxic, since when the frequency of micronuclei was compared among the groups there was no statistical difference.
It is important to highlight that the adoption of the cells analysis protocol in the serial monitoring periods of 24, 48 and 72 hours makes the data cross-check more robust to evaluate the material genotoxic action. According to ISO / EN10993-5 , for the cytotoxicity test, it is recommended 24 hours of biomaterial exposure, which means that one cell cycle is enough for cell viability to be expressed. A eukaryotic cell has a cell cycle of approximately 24 hours . Thus, in the present study the cells exposed to material extracts were not the same at the end of the 72 hour analysis. Therefore, the evaluation of three distinct cell cycles (24, 48 and 72 hours) demonstrates cell survival in successive generations. This can be considered a long term evaluation.
The immortalized osteoblast cell lineage (MG63) studied here has been used as model cells in biomaterials evaluation [59-61]. This cell type was chosen because of its reproducibility capabilities, and because the relationship of osteoblasts with the bone repair process in tissues makes it ideal for vitro assays researching new implants materials.
Biocompatibility of a material is closely related to cell behavior in contact with the material. Osseointegration between a biomaterial and bone is dependent on cell adhesion in the material, and for adequate adhesion it is necessary that the biomaterial be not cytotoxic to the cells, as demonstrated in our previous studies [4,12,13]. In the present study, the comet and micronucleus assays showed no DNA damage. In view of the observed results, the Ti-35Nb alloy does not present genotoxicity, reinforcing that this alloy is a promising material and constitutes an alternative in the substitution of currently used Titanium and/or Titanium alloys in dentistry and orthopedics.
All authors participated in the design, studies interpretation and data analysis and the manuscript review; DPA, ICSC, and BHG conducted the experiments, NSS and CPS supplied all reagents for the experiments, CAAC supplied the samples, and all authors participated in the manuscript writing.
The authors declared no potential conflicts of interests concerning the research, authorship, and/or publication of article.
This work was supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo – The State of São Paulo Research Foundation) [grant number 2013/20054-8].
Subscribe to our articles alerts and stay tuned.